The phrase "a decrease in morphological" is correct and usable in written English.
It can be used in contexts discussing changes or reductions in morphological aspects, such as in linguistics, biology, or other fields that analyze form and structure.
Example: "The study revealed a decrease in morphological diversity among the species over the past decade."
Alternatives: "a reduction in morphological" or "a decline in morphological".
Water stress limits the growth and leads to a decrease in morphological parameters, this reduction is accompanied by a synthesis of several molecules in particular proline and phenolic compounds, However, the AMF stimulates growth, and drives the water status in plants at an optimal level, thus confirming the role of mycorrhizal symbiosis in plant defense against biotic and abiotic stress.
Importantly, reductions in oxidative lipid metabolites were associated with a decrease in morphological changes and inflammatory responses in the small intestine, suggesting that UFP indeed mediated intestinal injury through lipid peroxidation in these metabolites.
Compared with the control (pH 7.0), P. lactiflora exhibited a decrease in all morphological parameters except leaf number when irrigated with pH 4.0 and 10.0 waters.
Application of suramin (100µM), a broad spectrum P2 receptor antagonist, also exerted a general decrease in morphological parameters (Fig. 5C).
The positive control for apoptosis and ESE-16-treated cells showed a decrease in cell density and morphological characteristics of apoptosis such as membrane blebbing and apoptotic bodies.
Consistent with the cell integrity assay, treatment with TMZ followed by CRAd-S-pk7 led to a cytopathic effect characterised by a decrease in cell density and morphological changes.
This decrease in morphological parameters is accompanied by a synthesis of several molecules in particular proline and phenolic compounds, known for their role in plant tolerance to adverse conditions.
For years, it was generally accepted that a decrease in tumour size based on morphological imaging correlated with treatment effect.
Bevacizumab is an anti-angiogenic drug that causes morphological changes with a decrease in vascularity followed by a decrease in attenuation and enhancement at imaging even though no changes in tumour size are necessarily seen.
Exposure of C6 glioma cells to QUE-NLs resulted in necrotic morphological changes and a decrease in the percentage of viable cells.
Early stage cells, which had begun the process of morphological remodelling, displayed a decrease in the levels of stable microtubules, whereas late-stage transformed cells that had acquired elongated OL-like processes displayed increases in the amount of stable tubulin filaments.
